APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. (September 2017)

Record Type:: Journal Article
Title:: APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. (September 2017)
Main Title:: APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria
Authors:: Mehdi, Delphine El
Grossi, Federico V.
Deschatelets, Pascal
Pullon, Humphrey
Tan, Lisa
Vega, Carolina A.
Francois, Cedric G.
Abstract:
Is Part Of:: Molecular immunology. Volume 89(2017:Sep.)
Journal:: Molecular immunology
Issue:: Volume 89(2017:Sep.)
Issue Display:: Volume 89 (2017)
Year:: 2017
Volume:: 89
Issue Sort Value:: 2017-0089-0000-0000
Page Start:: 115
Page End:
Publication Date:: 2017-09
Subjects:: Immunochemistry -- Periodicals
Molecular biology -- Periodicals
Immunochemistry -- Periodicals
Allergy and Immunology -- Periodicals
Molecular Biology -- Periodicals
Immunochimie -- Périodiques
Biologie moléculaire -- Périodiques
Immunochemistry
Molecular biology
Periodicals
Electronic journals
571.96
Journal URLs:: http://www.sciencedirect.com/science/journal/01615890 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.molimm.2017.06.039 ↗
Languages:: English
ISSNs:: 0161-5890
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5900.817700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 4649.xml